• InvestorRelations.png

    Investor Relations

Corporate Profile

OTCQX-Best-50-2018-Logo mini.png
OmniComm Systems, Inc. (OTCQB: OMCM) is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials.

 

Financial Reporting

Provided below are links to our financial statements as filed with the United States Securities and Exchange Commission.

SEC Filings
Corporate Governance
Information Request

2018 Annual Meeting 

The OmniComm Systems, Inc. 2018 Annual Meeting of Stockholders was held on June 7, 2018.

To learn more about this dynamic company and related investment opportunities, please contact our financial team by email at invrel@omnicomm.com

Contact Us      North America +1 877.468.6332      Europe +49 (0) 228 227 440      Click Here to Email Us

Contact Us
North America
+1 877.468.6332
Europe
+49 (0) 228 227 440
Click Here to Email Us